Concord Medical Services (NYSE:CCM) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

Concord Medical Services Holdings Limited (NYSE:CCM)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $4.38 and traded as high as $4.67. Concord Medical Services shares last traded at $4.1750, with a volume of 12,882 shares trading hands.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Concord Medical Services in a report on Friday, August 21st. Wall Street Zen raised shares of Concord Medical Services to a “hold” rating in a report on Saturday, August 15th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Concord Medical Services Stock Down 4.0%

The company has a 50 day simple moving average of $4.60 and a 200 day simple moving average of $4.39. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.